| NYSE: VRX | |
|---|---|
| Current Price: | 49.16 |
| Change: | -0.06 |
| Jan 27 | 20 minute delay | |
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops and markets prescription and nonprescription pharmaceutical products that make a meaningful difference in patients' lives. Valeant is focused in the neurology and dermatology therapeutic areas primarily in the United States, Canada, Mexico, Brazil, Australia, Switzerland and Central Europe.